SecBot SecBot
PRESS-RELEASE ·Filed Apr 8, 2026

OM

Outset Medical, Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed6mo ago WireGlobeNewswire
Press release · Regulatory
Actionable Insight • Neutral

Monitor insider activity and future 424 filings for potential secondary offerings; while this is a routine hiring-related grant, the size of Elliott’s award suggests strategic importance of commercial expansion. No immediate financial impact, but watch for increased operating expenses from new hires.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
OM ▲ +17.59% at T+60d
NEUTRAL call +17.59% · α vs SPY +6.81% · entry $4.32 → $5.08
Entry = T+0 close
Apr 8, 2026
via day close
T+1d
-2.78%
call -2.78% · α -2.72%
$4.20
settled 7mo ago
T+5d
+1.85%
call +1.85% · α -1.33%
$4.40
settled 6mo ago
T+20d
+4.40%
call +4.40% · α -3.17%
$4.51
settled 6mo ago
T+60d
+17.59%
call +17.59% · α +6.81%
$5.08
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Outset Medical announced equity awards to two new hires, including 96,000 RSUs to newly appointed Executive Vice President of Commercial Derick Elliott, as a material inducement to employment. The move is routine for new executive hires but signals confidence in future growth.

Key Facts

  • Equity awards granted outside of stockholder-approved plan under Nasdaq inducement exemption
  • 96,000 RSUs granted to new EVP of Commercial Derick Elliott
  • 10,380 RSUs granted to another new non-executive employee
  • RSUs vest over three years with 33.33% on first anniversary and remainder quarterly thereafter
  • Public announcement required under Nasdaq Listing Rule 5635(c)(4)

Financial Impact

Approximately $1.8 million in total grant-date fair value (based on ~$17.50/share, current market price)

dilutioncompensationshares outstanding

Risk Factors

  • Potential dilution if all RSUs vest and shares are issued
  • Lack of shareholder approval for these specific grants may draw scrutiny if pattern continues

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3270491
10 reports for OM
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for OM — sortable, filterable
TypeNow
Oct 21, 2026
4d ago
Press Release
NEUTRAL ★ 1/10
$4.17awaiting T+5—$4.09 (−1.92%)
Oct 6, 2026
19d ago
SC 13G/A
BULLISH ★ 5/10
$4.21 $3.84▼ −8.79%▼ −7.81%$4.09 (−2.85%)
Aug 28, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$3.82 $3.47▼ −9.16%▼ −9.02%$4.09 (+7.07%)
Aug 14, 2026
10w ago
144
BEARISH ★ 5/10
$4.51 $4.19▲ +7.10%▲ +5.90%$4.09 (+9.31%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$4.30 $4.02▼ −6.51%▼ −6.95%$4.09 (−4.88%)
May 19, 2026
22w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.38 $5.01▲ +14.38%▲ +12.58%$4.09 (−6.62%)
May 15, 2026
23w ago
144
NEUTRAL ★ 2/10
$3.72 $4.40▲ +18.28%▲ +16.66%$4.09 (+9.95%)
Apr 27, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$4.32 $4.33▲ +0.23%▼ −1.46%$4.09 (−5.32%)
Apr 24, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$4.41 $4.33▼ −1.81%▼ −2.21%$4.09 (−7.26%)
Apr 8, 2026
28w ago
Press Release
NEUTRAL ★ 3/10
$4.32 $4.40▲ +1.85%▼ −1.33%$4.09 (−5.32%)
Showing 10 of 10

US Market Status

Market Open — Closes in 1h 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 8, 2026